Pharmapedia Pro
Medicines/Generics/Crisantaspase

Crisantaspase

Generic medicine reference

Not yet clinically reviewed

This entry was migrated from the earlier Pharmapedia app bundle and has not been reviewed by a named clinician on this site. It is provided for educational reference only — verify dosage and safety information against current, authoritative sources and a qualified healthcare professional before any clinical use.

Spot an error in this entry? Submit a correction
Overview
Erwinaze ( asparaginase Erwinia chrysanthemi ) is used to treat acute lymphoblastic leukemia (ALL) in patients who have developed hypersensitivity to E. coli-derived asparaginase. Erwinaze is a cancer medication that interferes with the growth and spread of cancer cells. Erwinaze works by lowering the levels of asparagine in your body, a substance the cancer cells need to survive. Erwinaze is given as an intravenous infusion or intramuscular injection and is often given as part of a multi-agent chemotherapeutic regimen.
Indications
Erwinaze ( asparaginase Erwinia chrysanthemi ) is used to treat acute lymphoblastic leukemia (ALL) in patients who have developed hypersensitivity to E. coli-derived asparaginase. Erwinaze is a cancer medication that interferes with the growth and spread of cancer cells. Erwinaze works by lowering the levels of asparagine in your body, a substance the cancer cells need to survive. Erwinaze is given as an intravenous infusion or intramuscular injection and is often given as part of a multi-agent chemotherapeutic regimen.
Contraindications
Erwinaze should not be used in patients with a history of: Serious hypersensitivity reactions to Erwinaze, including anaphylaxis Serious pancreatitis with prior L-asparaginase therapy Serious thrombosis with prior L-asparaginase therapy Serious hemorrhagic events with prior L-asparaginase therapy
Side Effects
The severe or irreversible adverse effects of Crisantaspase, which give rise to further complications include Hepatotoxicity, Coma, Hemorrhage, Thrombosis, Stupor, Tremors, Hyperplasia, Hemorrhagic pancreatitis. Crisantaspase produces potentially life-threatening effects which include Hypotension, Bronchospasm, Anaphylaxis, Laryngeal edema, Urticaria. which are responsible for the discontinuation of Crisantaspase therapy. The symptomatic adverse reactions produced by Crisantaspase are more or less tolerable and if they become severe, they can be treated symptomatically, these include Abdominal distension, Drowsiness, Fatigue, Nausea, Vomiting, Fever, Abdominal pain, Confusion, Hyperglycemia, Increased serum bilirubin, Increased cholesterol, Hepatomegaly, Malabsorption, Confusion.
Warnings
Some people develop a life-threatening allergic reaction to Erwinaze. You will need to receive Erwinaze in a hospital or clinic setting to quickly treat any serious side effects that may occur. Get emergency medical help if you have any signs of an allergic reaction to Erwinaze: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Call your doctor at once if you have serious side effects such as severe pain in your upper stomach, nausea, and vomiting, easy bruising or bleeding, increased thirst or urination, sudden numbness or severe headache, warmth or swelling in your legs, or sudden problems with your vision, speech, or balance. Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies , and all medicines you use.
High Risk Groups
Some people develop a life-threatening allergic reaction to Erwinaze. You will need to receive Erwinaze in a hospital or clinic setting to quickly treat any serious side effects that may occur. Get emergency medical help if you have any signs of an allergic reaction to Erwinaze: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Call your doctor at once if you have serious side effects such as severe pain in your upper stomach, nausea, and vomiting, easy bruising or bleeding, increased thirst or urination, sudden numbness or severe headache, warmth or swelling in your legs, or sudden problems with your vision, speech, or balance. Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies , and all medicines you use.
Adult Dosage
20 IU/m2 (20 (20)) As recommended. IV — 4.8hourly
Child Dosage
100 (100 (100)) As recommended. I/V — daily for 10 days after treatment with vincristine and prednisone 600 units/kg (600 (600)) As recommended. I/M —
Neonatal Dosage
No neonatal dosage information is recorded for this medicine yet.
Drug Interactions
Other drugs may interact with asparaginase Erwinia chrysanthemi, including prescription and over-the-counter medicines, vitamins , and herbal products . Tell your doctor about all other medicines you use.
Storage
Inj (reconstituted soln) Store at room temperature. Use within 15 min if kept at room temperature. Powder for Inj Store in refrigerator.

Available Brands in Pakistan

No active brands are currently recorded for this generic.

2 records are present but flagged "Unverified / Legacy" and excluded.